Skip to main content

Research Repository

Advanced Search

Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing

van Bree, Niek; Oppelt, Ann-Sophie; Lindström, Susanne; Zhou, Leilei; Boutin, Lola; Coyle, Beth; Swartling, Fredrik J; Johnsen, John Inge; Bräutigam, Lars; Wilhelm, Margareta

Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing Thumbnail


Authors

Niek van Bree

Ann-Sophie Oppelt

Susanne Lindström

Leilei Zhou

Lola Boutin

Fredrik J Swartling

John Inge Johnsen

Lars Bräutigam

Margareta Wilhelm



Abstract

Background

Medulloblastoma (MB) is one of the most common malignant brain tumors in children. Current preclinical in vivo model systems for MB have increased our understanding of molecular mechanisms regulating MB development. However, they may not be suitable for large-scale studies. The aim of this study was to investigate if a zebrafish-based xenograft model can recapitulate MB growth and enable rapid drug testing.

Methods

Nine different MB cell lines or patient-derived cells were transplanted into blastula-stage zebrafish embryos. Tumor development and migration were then monitored using live imaging. RNA sequencing was performed to investigate transcriptome changes after conditioning cells in neural stem cell-like medium. Furthermore, drug treatments were tested in a 96-well format.

Results

We demonstrate here that transplantation of MB cells into the blastula stage of zebrafish embryos leads to orthotopic tumor growth that can be observed within 24 hours after transplantation. Importantly, the homing of transplanted cells to the hindbrain region and the aggressiveness of tumor growth are enhanced by pre-culturing cells in a neural stem cell-like medium. The change in culture conditions rewires the transcriptome towards a more migratory and neuronal phenotype, including the expression of guidance molecules SEMA3A and EFNB1, both of which correlate with lower overall survival in MB patients. Furthermore, we highlight that the orthotopic zebrafish MB model has the potential to be used for rapid drug testing.

Conclusion

Blastula-stage zebrafish MB xenografts present an alternative to current MB mouse xenograft models, enabling quick evaluation of tumor cell growth, neurotropism, and drug efficacy.

Citation

van Bree, N., Oppelt, A.-S., Lindström, S., Zhou, L., Boutin, L., Coyle, B., Swartling, F. J., Johnsen, J. I., Bräutigam, L., & Wilhelm, M. (2024). Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing. Neuro-Oncology, https://doi.org/10.1093/neuonc/noae210

Journal Article Type Article
Acceptance Date Oct 7, 2024
Online Publication Date Oct 9, 2024
Publication Date Oct 9, 2024
Deposit Date Oct 24, 2024
Publicly Available Date Oct 28, 2024
Journal Neuro-Oncology
Print ISSN 1522-8517
Electronic ISSN 1523-5866
Publisher Oxford University Press
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1093/neuonc/noae210
Keywords medulloblastoma, neurotropism, patient-derived xenografts, rapid drug testing, zebrafish
Public URL https://nottingham-repository.worktribe.com/output/40705660
Publisher URL https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noae210/7816290

Files






You might also like



Downloadable Citations